144 related articles for article (PubMed ID: 28978153)
1. Concurrent somatic mutations in driver genes were significantly correlated with lymph node metastasis and pathological types in solid tumors.
Cheng Y; Wang S; Han L; Liu P; Li H; Ren X; Yu J; Hao X
Oncotarget; 2017 Sep; 8(40):68746-68757. PubMed ID: 28978153
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
[TBL] [Abstract][Full Text] [Related]
3. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
4. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
5. Molecular Signatures of
Hsu J; Annunziata JF; Burns E; Bernicker EH; Olsen RJ; Thomas JS
Clin Pathol; 2022; 15():2632010X221102054. PubMed ID: 35634237
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and breakdown of non-small cell lung cancer BRAF driver mutations in a large UK cohort.
Lim GHT; Balbi KJ; Poskitt B; Bennett P; Moore DA
Lung Cancer; 2022 Nov; 173():71-74. PubMed ID: 36156323
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer.
Niu L; Dang C; Li L; Guo N; Xu Y; Li X; Xu Q; Cheng L; Zhang L; Liu L
Oncol Lett; 2021 Aug; 22(2):594. PubMed ID: 34149905
[TBL] [Abstract][Full Text] [Related]
9. The co-mutation of
Zhang Y; Li S; Lyu Z; Cai J; Zheng N; Li Y; Xu T; Zeng H
J Thorac Dis; 2022 Jan; 14(1):185-193. PubMed ID: 35242380
[TBL] [Abstract][Full Text] [Related]
10. Genetic alteration profile of
Deng Q; Qiu Y; Jia J; Tang H; Liu L; Huang L; He D; Dong X; Yang H
Transl Lung Cancer Res; 2019 Dec; 8(6):838-846. PubMed ID: 32010562
[TBL] [Abstract][Full Text] [Related]
11. Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer.
Chen B; Li R; Zhang J; Xu L; Jiang F
Pathol Oncol Res; 2022; 28():1610020. PubMed ID: 35783357
[No Abstract] [Full Text] [Related]
12. Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Chen M; Xu Y; Zhao J; Zhong W; Zhang L; Bi Y; Wang M
EBioMedicine; 2019 Apr; 42():304-310. PubMed ID: 30878600
[TBL] [Abstract][Full Text] [Related]
13. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
[TBL] [Abstract][Full Text] [Related]
14. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.
Wang L; Diao M; Zhang Z; Jiang M; Chen S; Zhao D; Liu Z; Zhou C
Lung Cancer; 2024 Jan; 187():107439. PubMed ID: 38113653
[TBL] [Abstract][Full Text] [Related]
16. Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Wu Y; Ni H; Yang D; Niu Y; Chen K; Xu J; Wang F; Tang S; Shi Y; Zhang H; Hu J; Xia D; Wu Y
Pathol Res Pract; 2021 Aug; 224():153551. PubMed ID: 34298439
[TBL] [Abstract][Full Text] [Related]
17. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
Shen E; Xiu J; Bentley R; López GY; Walsh KM
Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
[TBL] [Abstract][Full Text] [Related]
18. The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer.
Liu Z; Liang H; Lin J; Cai X; Pan Z; Liu J; Xie X; Li C; Cheng B; Zhao Y; He J; Liang W
Lung Cancer; 2019 Aug; 134():218-224. PubMed ID: 31319984
[TBL] [Abstract][Full Text] [Related]
19. The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.
Cao L; Long L; Li M; Yang H; Deng P; Mao X; Xiang J; Li B; Zhang T; Hu C
Onco Targets Ther; 2018; 11():2637-2646. PubMed ID: 29780256
[TBL] [Abstract][Full Text] [Related]
20. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
